168 related articles for article (PubMed ID: 3139924)
1. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
[TBL] [Abstract][Full Text] [Related]
2. Multisystem triglyceride storage disease is due to a specific defect in the degradation of endocellularly synthesized triglycerides.
Di Donato S; Garavaglia B; Strisciuglio P; Borrone C; Andria G
Neurology; 1988 Jul; 38(7):1107-10. PubMed ID: 3386830
[TBL] [Abstract][Full Text] [Related]
3. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.
Radom J; Salvayre R; Levade T; Douste-Blazy L
Biochem J; 1990 Jul; 269(1):107-13. PubMed ID: 2165389
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy.
Radom J; Salvayre R; Maret A; Nègre A; Douste-Blazy L
Biochim Biophys Acta; 1987 Jul; 920(2):131-9. PubMed ID: 3607075
[TBL] [Abstract][Full Text] [Related]
5. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts.
Igal RA; Coleman RA
J Biol Chem; 1996 Jul; 271(28):16644-51. PubMed ID: 8663220
[TBL] [Abstract][Full Text] [Related]
6. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways.
Hilaire N; Salvayre R; Thiers JC; Bonnafé MJ; Nègre-Salvayre A
J Biol Chem; 1995 Nov; 270(45):27027-34. PubMed ID: 7592952
[TBL] [Abstract][Full Text] [Related]
7. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease.
Salvayre R; Negre A; Maret A; Radom J; Douste-Blazy L
Eur J Biochem; 1987 Dec; 170(1-2):453-8. PubMed ID: 3691534
[TBL] [Abstract][Full Text] [Related]
8. Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism.
Williams ML; Coleman RA; Placezk D; Grunfeld C
Biochim Biophys Acta; 1991 Feb; 1096(2):162-9. PubMed ID: 2001430
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and ultrastructural features of human fibroblasts cultured from a new variant of type 3 lipid storage myopathy.
Radom J; Salvayre R; Mussini JM; De Lisle B; Negre A; Maret A; Billaudel S; Douste-Blazy L
Biol Cell; 1988; 62(1):39-45. PubMed ID: 3365518
[TBL] [Abstract][Full Text] [Related]
10. Neutral lipid storage disease with ichthyosis: serum apolipoprotein levels and cholesterol metabolism in monocyte-derived macrophages.
Bergman R; Aviram M; Bitterman-Deutsch O; Oiknine Y; Shemer A; Srebnik A; Brook JG; Friedman-Birnbaum R
J Inherit Metab Dis; 1991; 14(2):241-6. PubMed ID: 1909403
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.
Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL
Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511
[TBL] [Abstract][Full Text] [Related]
12. Neutral lipid storage disease with ichthyosis. Defective lamellar body contents and intracellular dispersion.
Elias PM; Williams ML
Arch Dermatol; 1985 Aug; 121(8):1000-8. PubMed ID: 4026335
[TBL] [Abstract][Full Text] [Related]
13. Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.
Brown AL; Mark Brown J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt B):1233-1241. PubMed ID: 28827091
[TBL] [Abstract][Full Text] [Related]
14. Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.
Tavian D; Missaglia S; Redaelli C; Pennisi EM; Invernici G; Wessalowski R; Maiwald R; Arca M; Coleman RA
Hum Mol Genet; 2012 Dec; 21(24):5318-28. PubMed ID: 22990388
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lipid profile in lipid storage myopathy.
Aguennouz M; Beccaria M; Purcaro G; Oteri M; Micalizzi G; Musumesci O; Ciranni A; Di Giorgio RM; Toscano A; Dugo P; Mondello L
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():157-168. PubMed ID: 27428459
[TBL] [Abstract][Full Text] [Related]
16. Neutral lipid storage disease. Case report and lipid studies.
Judge MR; Atherton DJ; Salvayre R; Hilaire N; Levade T; Johnston DI; Winchester B; Lake BD
Br J Dermatol; 1994 Apr; 130(4):507-10. PubMed ID: 8186119
[TBL] [Abstract][Full Text] [Related]
17. The important role of epidermal triacylglycerol metabolism for maintenance of the skin permeability barrier function.
Radner FP; Fischer J
Biochim Biophys Acta; 2014 Mar; 1841(3):409-15. PubMed ID: 23928127
[TBL] [Abstract][Full Text] [Related]
18. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
19. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation.
Angelini C; Philippart M; Borrone C; Bresolin N; Cantini M; Lucke S
Ann Neurol; 1980 Jan; 7(1):5-10. PubMed ID: 7362208
[TBL] [Abstract][Full Text] [Related]
20. Systemic triglyceride storage disease with normal carnitine: a putative defect in long-chain fatty acid metabolism.
Ibayashi H; Ideguchi H; Harada N; Ishimoto S; Goto I
J Neurol Sci; 1988 Jun; 85(2):149-59. PubMed ID: 3385431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
